{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:06:12Z","timestamp":1791421572713,"version":"4.3.3"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"British Heart Foundation (DS&SJW)"},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["093080\/Z\/10\/Z"],"award-info":[{"award-number":["093080\/Z\/10\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"MRC","doi-asserted-by":"publisher","award":["G1001367\/1"],"award-info":[{"award-number":["G1001367\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Ferrara and the Consorzio Ferrara Ricerche (GC)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.bbrc.2014.06.111","type":"journal-article","created":{"date-parts":[[2014,7,5]],"date-time":"2014-07-05T11:00:17Z","timestamp":1404558017000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension"],"prefix":"10.1016","volume":"451","author":[{"given":"Dongmin","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Perros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Caramori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dormuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pai-Chien","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Papi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Casolari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Adcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Wort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.06.111_b0005","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.phrs.2011.03.003","article-title":"The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension","volume":"63","author":"Shao","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2014.06.111_b0010","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1183\/09031936.03.00038903","article-title":"Inflammation in pulmonary arterial hypertension","volume":"22","author":"Dorfmuller","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbrc.2014.06.111_b0015","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","article-title":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension","volume":"151","author":"Humbert","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbrc.2014.06.111_b0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1183\/09031936.00104706","article-title":"Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension","volume":"29","author":"Perros","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbrc.2014.06.111_b0025","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1164\/ajrccm.165.4.2012112","article-title":"Chemokine RANTES in severe pulmonary arterial hypertension","volume":"165","author":"Dorfmuller","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbrc.2014.06.111_b0030","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1164\/rccm.200610-1559OC","article-title":"Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension","volume":"176","author":"Sanchez","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbrc.2014.06.111_b0035","doi-asserted-by":"crossref","first-page":"e75415","DOI":"10.1371\/journal.pone.0075415","article-title":"Nuclear factor kappa-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension","volume":"8","author":"Price","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbrc.2014.06.111_b0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.it.2009.03.003","article-title":"Interleukin-33 \u2013 cytokine of dual function or novel alarmin?","volume":"30","author":"Haraldsen","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbrc.2014.06.111_b0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.immuni.2009.06.011","article-title":"IL-33 raises alarm","volume":"31","author":"Lamkanfi","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2014.06.111_b0050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2222.2009.03384.x","article-title":"IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma","volume":"40","author":"Smith","year":"2010","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.bbrc.2014.06.111_b0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nri2692","article-title":"Disease-associated functions of IL-33: the new kid in the IL-1 family","volume":"10","author":"Liew","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2014.06.111_b0060","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1073\/pnas.0812690106","article-title":"The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1","volume":"106","author":"Cayrol","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.06.111_b0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-5793(89)81679-5","article-title":"A putative protein of a growth specific cDNA from BALB\/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor","volume":"258","author":"Tominaga","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2014.06.111_b0070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2014.06.111_b0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/hyb.1995.14.419","article-title":"Studies on natural ST2 gene products in the human leukemic cell line UT-7 using monoclonal antihuman ST2 antibodies","volume":"14","author":"Yoshida","year":"1995","journal-title":"Hybridoma"},{"key":"10.1016\/j.bbrc.2014.06.111_b0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9440(10)63631-0","article-title":"Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules","volume":"163","author":"Baekkevold","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2014.06.111_b0085","doi-asserted-by":"crossref","first-page":"250938","DOI":"10.1155\/2013\/250938","article-title":"Interleukin-33 drives activation of alveolar macrophages and airway inflammation in a mouse model of acute exacerbation of chronic asthma","volume":"2013","author":"Bunting","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbrc.2014.06.111_b0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4168\/aair.2011.3.2.81","article-title":"IL-33 and airway inflammation","volume":"3","author":"Oboki","year":"2011","journal-title":"Allergy Asthma Immunol. Res."},{"key":"10.1016\/j.bbrc.2014.06.111_b0095","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1172\/JCI65570","article-title":"Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease","volume":"123","author":"Byers","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2014.06.111_b0100","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/thoraxjnl-2012-203062","article-title":"Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD","volume":"69","author":"Di Stefano","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.bbrc.2014.06.111_b0105","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2014.06.111_b0110","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/CIRCHEARTFAILURE.109.873240","article-title":"Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling","volume":"2","author":"Seki","year":"2009","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.bbrc.2014.06.111_b0115","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2014.06.111_b0120","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/erm.10.25","article-title":"ST2: a novel biomarker for heart failure","volume":"10","author":"Bhardwaj","year":"2010","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.bbrc.2014.06.111_b0125","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1309\/WMG2BFRC97MKKQKP","article-title":"Soluble ST2 plasma concentrations predict 1-year mortality in acutely dyspneic emergency department patients with pulmonary disease","volume":"130","author":"Martinez-Rumayor","year":"2008","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bbrc.2014.06.111_b0130","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.ijcard.2012.12.031","article-title":"Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension","volume":"168","author":"Carlomagno","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbrc.2014.06.111_b0135","doi-asserted-by":"crossref","first-page":"e30075","DOI":"10.1371\/journal.pone.0030075","article-title":"BMP-9 induced endothelial cell tubule formation and inhibition of migration involves Smad1 driven endothelin-1 production","volume":"7","author":"Park","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbrc.2014.06.111_b0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20050466","article-title":"Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression","volume":"203","author":"Ito","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2014.06.111_b0145","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2353\/ajpath.2008.080014","article-title":"Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation","volume":"173","author":"Kuchler","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2014.06.111_b0150","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0606854104","article-title":"IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo","volume":"104","author":"Carriere","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.06.111_b0155","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1517\/14728222.2012.719500","article-title":"Targeting PDGF pathway in pulmonary arterial hypertension","volume":"16","author":"Antoniu","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbrc.2014.06.111_b0160","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1172\/JCI32503","article-title":"An antiproliferative BMP-2\/PPARgamma\/apoE axis in human and murine SMCs and its role in pulmonary hypertension","volume":"118","author":"Hansmann","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2014.06.111_b0165","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.pupt.2006.08.007","article-title":"P38 MAP kinase: essential role in hypoxia-mediated human pulmonary artery fibroblast proliferation","volume":"20","author":"Mortimer","year":"2007","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2014.06.111_b0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11897-010-0005-9","article-title":"ST2: a novel remodeling biomarker in acute and chronic heart failure","volume":"7","author":"Shah","year":"2010","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.bbrc.2014.06.111_b0175","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1038\/onc.2011.525","article-title":"Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis","volume":"31","author":"Gillibert-Duplantier","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2014.06.111_b0180","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1165\/ajrcmb.25.5.4592","article-title":"P27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation","volume":"25","author":"Fouty","year":"2001","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbrc.2014.06.111_b0185","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/01.RES.0000141428.53262.a4","article-title":"Rho kinase-induced nuclear translocation of ERK1\/ERK2 in smooth muscle cell mitogenesis caused by serotonin","volume":"95","author":"Liu","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2014.06.111_b0190","doi-asserted-by":"crossref","first-page":"17525","DOI":"10.1074\/jbc.M210465200","article-title":"Activation of GATA-4 by serotonin in pulmonary artery smooth muscle cells","volume":"278","author":"Suzuki","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.06.111_b0195","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/rccm.201001-0123OC","article-title":"Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy","volume":"182","author":"Ghofrani","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbrc.2014.06.111_b0200","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1164\/rccm.200811-1682OC","article-title":"Role of epidermal growth factor inhibition in experimental pulmonary hypertension","volume":"181","author":"Dahal","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbrc.2014.06.111_b0205","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.4049\/jimmunol.1003080","article-title":"The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription","volume":"187","author":"Ali","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2014.06.111_b0210","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbrc.2012.04.005","article-title":"Nuclear IL-33 is a transcriptional regulator of NF-kappaB p65 and induces endothelial cell activation","volume":"421","author":"Choi","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2014.06.111_b0215","doi-asserted-by":"crossref","first-page":"32689","DOI":"10.1074\/jbc.M112.374876","article-title":"GATA2 is a critical transactivator for the human IL1RL1\/ST2 promoter in mast cells\/basophils: opposing roles for GATA2 and GATA1 in human IL1RL1\/ST2 gene expression","volume":"287","author":"Baba","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.06.111_b0220","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/eji.201142274","article-title":"Deletion of the ST2 proximal promoter disrupts fibroblast-specific expression but does not reduce the amount of soluble ST2 in circulation","volume":"42","author":"Lipsky","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbrc.2014.06.111_b0225","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11010-009-0244-9","article-title":"ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells","volume":"335","author":"Aoki","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2014.06.111_b0230","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.yexcr.2008.10.012","article-title":"The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes","volume":"315","author":"Rascle","year":"2009","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2014.06.111_b0235","doi-asserted-by":"crossref","first-page":"17469","DOI":"10.1073\/pnas.0809527105","article-title":"Role for beta-catenin and HOX transcription factors in Caenorhabditis elegans and mammalian host epithelial-pathogen interactions","volume":"105","author":"Irazoqui","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.06.111_b0240","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pcad.2012.07.006","article-title":"Immune and inflammatory mechanisms in pulmonary arterial hypertension","volume":"55","author":"El Chami","year":"2012","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.bbrc.2014.06.111_b0245","doi-asserted-by":"crossref","first-page":"18581","DOI":"10.1073\/pnas.1003059107","article-title":"IL-33 is a crucial amplifier of innate rather than acquired immunity","volume":"107","author":"Oboki","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.06.111_b0250","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1074\/jbc.M111.298703","article-title":"Interleukin 33 as a mechanically responsive cytokine secreted by living cells","volume":"287","author":"Kakkar","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.06.111_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2014.02.012","article-title":"Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation","author":"Bessa","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbrc.2014.06.111_b0260","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/CIRCULATIONAHA.108.847707","article-title":"Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies","volume":"121","author":"Archer","year":"2010","journal-title":"Circulation"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14011851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14011851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T17:56:17Z","timestamp":1538416577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14011851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0006291X14011851"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.06.111","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.06.111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}